Aurora Medical Technologies
PrivateLast Round
Grant
Mar 12, 2025
Total Funding Raised
$35,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aurora Medical Technologies operates in Healthcare & Life Sciences and is based in Minneapolis, Minnesota. Its latest recorded funding round was a Grant round in March 2025.
Aurora Medical Technologies is a medical device company that develops a tissue-anchoring architecture and suturing-based platform designed to support precision intervention across endoscopic procedural workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aurora Medical Technologies Comparables
Compare Aurora Medical Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnVision Endoscopy | 88% | |
| Endo Tools Therapeutics | 81% | |
| Samothrace Medical Innovations Inc. | 81% |
For institutional investors. Book with your work email.
Aurora Medical Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 12, 2025 | ||||
| Seed | Nov 5, 2024 | ||||
| Accelerator | Jun 7, 2024 | ||||
| Seed | Mar 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aurora Medical Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launch Minnesota | Grant, Seed |
| SBXi | Seed |
| LaunchMN | Seed |
| Groove Capital | Seed |
| Purdue Strategic Ventures | Seed |
| Highcroft Capital | Seed |
| Fogarty Innovation | Accelerator, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 104% MoM, reaching 1.7K.
- Feb 4, 2026
Added Vita Group, a manufacturing/materials science company, as a customer.
For institutional investors. Book with your work email.
Aurora Medical Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aurora Medical Technologies's valuation, stock price, and market status.
Is Aurora Medical Technologies a public or private company?
Aurora Medical Technologies is a private company.
What is the current stock price of Aurora Medical Technologies?
Aurora Medical Technologies is a private company, so its shares have no public market price. Caplight tracks Aurora Medical Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aurora Medical Technologies worth (valuation)?
Valuation information for Aurora Medical Technologies is not publicly available.
Can I buy Aurora Medical Technologies stock?
Aurora Medical Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aurora Medical Technologies's last funding round?
Aurora Medical Technologies's most recent funding round was Grant on March 12, 2025.
Who are the main investors in Aurora Medical Technologies?
Key investors in Aurora Medical Technologies include Launch Minnesota, SBXi, LaunchMN, Groove Capital, Purdue Strategic Ventures.
Will Aurora Medical Technologies IPO soon?
No public IPO plans have been announced for Aurora Medical Technologies.
How can I track Aurora Medical Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Aurora Medical Technologies's shares on secondary markets.